These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9037321)

  • 1. The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balance.
    Haenni A; Berglund L; Reneland R; Anderssson PE; Lind L; Lithell H
    Am J Hypertens; 1997 Feb; 10(2):145-51. PubMed ID: 9037321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men.
    Reneland R; Haenni A; Andersson PE; Andrén B; Lithell H
    Blood Press; 1999; 8(1):16-22. PubMed ID: 10412878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
    Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blood pressure response to antihypertensive treatment with lisinopril or bendrofluazide is related to the calcium and magnesium contents in skeletal muscle.
    Haenni A; Lind L; Lithell H
    Am J Hypertens; 1996 Mar; 9(3):273-6. PubMed ID: 8695028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor index: a novel method for measuring pharmacological inhibition of angiotensin-converting enzyme.
    Reneland R; Lithell H
    Blood Press; 1997 Mar; 6(2):103-8. PubMed ID: 9105649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.
    Oksa A; Gajdos M; Fedelesová V; Spustová V; Dzúrik R
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):79-86. PubMed ID: 7511740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition.
    Reneland R; Andersson PE; Haenni A; Lithell H
    Eur J Clin Pharmacol; 1994; 46(5):431-6. PubMed ID: 7957538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.
    Herrera-Arellano A; Miranda-Sánchez J; Avila-Castro P; Herrera-Alvarez S; Jiménez-Ferrer JE; Zamilpa A; Román-Ramos R; Ponce-Monter H; Tortoriello J
    Planta Med; 2007 Jan; 73(1):6-12. PubMed ID: 17315307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial.
    Suliburska J; Skrypnik K; Szulińska M; Kupsz J; Markuszewski L; Bogdański P
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30208601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients.
    Fogari R; Zoppi A; Corradi L; Lazzari P; Mugellini A; Lusardi P
    Br J Clin Pharmacol; 1998 Nov; 46(5):467-71. PubMed ID: 9833600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients.
    Thürig C; Böhlen L; Schneider M; de Courten M; Shaw SG; Riesen W; Weidmann P
    Eur J Clin Pharmacol; 1995; 49(1-2):21-6. PubMed ID: 8751016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: A comparative study with lisinopril.
    Nwachukwu DC; Aneke EI; Obika LF; Nwachukwu NZ
    Indian J Pharmacol; 2015; 47(5):540-5. PubMed ID: 26600645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
    Sarro GD; Paola ED; Gratteri S; Gareri P; Rispoli V; Siniscalchi A; Tripepi G; Gallelli L; Citraro R; Russo E
    Pharmacol Res; 2012 Mar; 65(3):285-96. PubMed ID: 22107891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular wall thickness during ACE-inhibitor treatment of essential hypertension is associated with an increase in insulin mediated skeletal muscle blood flow.
    Andersson PE; Lind L; Andrén B; Hänni A; Reneland R; Berne C; Lithell H
    Blood Press; 1998 May; 7(2):118-26. PubMed ID: 9657539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using ACE inhibitors appropriately.
    Bicket DP
    Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
    Díez J; Laviades C
    J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.